Literature DB >> 8091999

The vulnerability/stress model of schizophrenic relapse: a longitudinal study.

K H Nuechterlein1, M E Dawson, J Ventura, M Gitlin, K L Subotnik, K S Snyder, J Mintz, G Bartzokis.   

Abstract

A tentative model for conceptualizing the interplay of vulnerability factors, stressors, and protective factors in the course of schizophrenia is discussed. A study of the initial years after a first schizophrenic episode is testing the predictive role of key factors. During an initial 1-year period of depot antipsychotic medication, independent life events and expressed emotion were found to predict the likelihood of psychotic relapse. Initial analyses indicate that independent life events play less of a role in relapse prediction during a medication-free period. These results suggest that maintenance antipsychotic medication raises the threshold for return of psychotic symptoms, such that relapses are less likely unless major environmental stressors occur. A low expressed emotion environment may be a protective factor.

Entities:  

Mesh:

Year:  1994        PMID: 8091999     DOI: 10.1111/j.1600-0447.1994.tb05867.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  37 in total

1.  Life event exposure, physiological reactivity, and psychological strain.

Authors:  K Clements; G Turpin
Journal:  J Behav Med       Date:  2000-02

Review 2.  The stress-vulnerability hypothesis in psychotic disorders: focus on the stress response systems.

Authors:  Christine C Gispen-de Wied; Lucres M C Jansen
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

3.  Effect of adrenalectomy and corticosterone replacement on prepulse inhibition and locomotor activity in mice.

Authors:  Maarten van den Buuse; Margaret Morris; Carolina Chavez; Sally Martin; JianHong Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

4.  Family caregivers' monitoring of medication usage: a qualitative study of Mexican-origin families with serious mental illness.

Authors:  Jorge A Marquez; Jorge I Ramírez García
Journal:  Cult Med Psychiatry       Date:  2011-03

Review 5.  Psychotherapy for schizophrenia in the year 2030: prognosis and prognostication.

Authors:  William Spaulding; Jeffrey Nolting
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

6.  Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses.

Authors:  Mario Pfammatter; Ulrich Martin Junghan; Hans Dieter Brenner
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

7.  Enduring sensorimotor gating abnormalities following predator exposure or corticotropin-releasing factor in rats: a model for PTSD-like information-processing deficits?

Authors:  Vaishali P Bakshi; Karen M Alsene; Patrick H Roseboom; Elenora E Connors
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

8.  Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.

Authors:  Nancy C Andreasen; Dawei Liu; Steven Ziebell; Anvi Vora; Beng-Choon Ho
Journal:  Am J Psychiatry       Date:  2013-06       Impact factor: 18.112

9.  Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia.

Authors:  Sarah J Hart; Joseph J Shaffer; Joshua Bizzell; Mariko Weber; Mary A McMahon; Hongbin Gu; Diana O Perkins; Aysenil Belger
Journal:  J Vis Exp       Date:  2015-12-02       Impact factor: 1.355

10.  Altered fronto-limbic activity in children and adolescents with familial high risk for schizophrenia.

Authors:  Sarah J Hart; Joshua Bizzell; Mary Agnes McMahon; Hongbin Gu; Diana O Perkins; Aysenil Belger
Journal:  Psychiatry Res       Date:  2013-03-06       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.